在高维度药物基因组学中使用多重输入改进基因型输入:用机器学习方法进行评估
Innocent G Asiimwe1, Tao You2, Daniel F Carr2
1Department of Health Data Science, Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.
Clinical pharmacology and therapeutics
|December 17, 2025
概括
多重归算通过提高数据准确性来提高高维药基因组学的可靠性. 这种方法优于处理遗传数据缺失的传统方法,从而更好地发现重要的遗传关联.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 生物信息学是一种生物信息学.
- 统计遗传学 统计遗传学
背景情况:
- 在高维基遗传数据集中处理丢失的数据是具有挑战性的.
- 传统的归算方法在复杂的遗传分析中往往不足.
- 多重归算 (MI) 已建立,但在此背景下未得到充分利用.
研究的目的:
- 在高维基遗传数据中比较机器学习 (ML) 和传统的归算和共变量选择方法.
- 开发和评估一个包含基因型概率和归算不确定性的MI框架.
- 评估MI在恢复药物基因组学关联和改善发现方面的表现.
主要方法:
- 开发了一种新的多重归算框架,使用基因型概率,INFO分数和失踪百分比.
- 采用随机森林和惩罚性回归来减少可扩展的共变量选择的维度.
- 使用药理动力学结核模拟,1000个基因组项目的SNP数据和临床华法林数据集 (War-PATH,IWPC,英国生物银行) 的验证方法.
主要成果:
- 在模拟中,多次归算显著改善了信心区间覆盖率 (高达94%) 与单次归算 (0%) 相比.
- 在临床数据集中,MI成功地恢复了已知的药物基因组学关联 (例如,CYP2C9,VKORC1) 并确定了新信号 (例如,rs4697699).
- 处罚回归在高效应SNP选择中表现出色 (F1=0.897),而GWAS+随机森林在低效应场景中表现更好 (F1=0.657).
结论:
- 多重归算在高维的药物基因组学研究中提高了可靠性和发现能力.
- ML方法显示了SNP选择的潜力,但需要进一步研究以获得一致的好处.
- 对生物库规模分析的可扩展性和通用性仍然是未来研究的关键领域.
相关概念视频
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
461
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
461
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Model Approaches for Pharmacokinetic Data: Compartment Models
502
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
502
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
293
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
293
Mechanistic Models: Compartment Models in Individual and Population Analysis
226
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
226


